|
Allergy Relief / Allergy Medicine / Perrigo, Teva Get Allergy Drug Approval
Perrigo, Teva Get Allergy Drug Approval
NEW YORK — Drug developer Perrigo Co. said Thursday its partner Teva Pharmaceutical Industries Ltd. received Food and Drug Administration approval to sell an over-the-counter version of the allergy treatment Zyrtec-D.
The generic version will be sold by Perrigo under store brand names. McNeil Consumer Healthcare, a unit of Johnson & Johnson, said launched is over-the-counter version of Zyrtec in January.
Perrigo said it plans to ship the product in the next 90 days.
Shares of Allegan, Mich.-based Perrigo fell 94 cents, or 2.8 percent, to $32.78 in afternoon trading. The stock has traded between $16.09 and $36.86 over the last 52 weeks. Shares of Israel-based Teva fell $1.43, or 2.9 percent, to $48.13.
From http://www.chron.com/disp/story.mpl/ap/fn/5598706.
Previous Page: New tools help MDs treat allergies Next Page: Pollen count in sneezy Southeast Texas expected to be worse than national levels
DISCLAIMER: The information contained in this site is for educational purposes only, and should not be used as a substitute for personal care by a licensed physician. Please see your physician for diagnosis and treatment of any concerning symptoms or medical condition.
|
